Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Monoclonal Remove


August 2014
Sa Fr Th We Tu Mo Su
30 29 28 27 26 25 24

monoclonal Press Releases

  + XML/RSS  



By SMi Group
Biosimilars for recombinant human insulin and insulin glargine

By SMi Group
Consider novel linker strategy techniques to increase efficacy of ADC products

By Frost & Sullivan
Frost & Sullivan hosts complimentary webinar discussing the potential benefits and risks of an untapped market

By Visiongain
A new report by Visiongain predicts that overall revenues for monoclonal antibody (mAb) therapies will rise between 2011 and 2021. The world mAb drugs market will reach $62.3bn in 2015, up from revenues of $44.6bn (USD) in 2010.

By Health, Medical, Research
New Healthcare market report from Datamonitor: "R&D Trends: HIV - An active pipeline faces fierce competition in the HIV market"

By ReportBuyer.com
According to our new research report 'Global Monoclonal Antibody Market Analysis', the global monoclonal antibodies market witnessed an annual growth rate of around 13% during 2008-2009.

By Kalorama Information
Although the therapeutic vaccine market has experienced a range of setbacks and disappointments, technological evolution should ultimately enable therapeutic vaccines to make similar commercial breakthroughs as monoclonal antibodies, notes Kalorama.

By Bharatbook
Bharatbook added a new report on "Therapeutic Monoclonal Antibodies: World Market 2010-2025" which gives the potential applications and prospects on worldwide Therapeutic Monoclonal Antibodies.

By MarketsandMarkets
The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008.

By Randox Laboratories
Randox Life Sciences is a recognised primary manufacturer of high quality, cost effective monoclonal antibodies to both classic and novel targets.

By Bharatbook
MedImmune has agreed to license the rights to develop Trellis Bioscience's monoclonal antibody products for the treatment of respiratory syncytial virus (RSV).

By Heidi Stenhouse
Lab901 to present their Protein ScreenTape(R) platform

By Fast Market Research
New Pharmaceuticals research report from Business Insights is now available from Fast Market Research

By Fast Market Research
Recently published research from Business Insights, "Preclinical Development of Monoclonal Antibodies and Related Biologicals: Emerging technologies and new therapeutic candidates", is now available at Fast Market Research

By reports.research.com
Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as our new market report explains.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share